Associate Professor Murdoch University Kardinya, Western Australia, Australia
Presentation Description / Summary: This session will use case-based scenarios in dogs and cats to illustrate the application of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) guidelines to practice. Cases will include IMHA in a dog that goes on to require therapeutic plasma exchange, cardiomyopathy in a cat that develops aortic thromboembolism, and protein losing nephropathy in a dog.
Learning Objectives:
Apply evidence-based recommendations to select appropriate antithrombotic or thrombolytic strategies for dogs and cats with high-risk conditions such as IMHA, cardiomyopathy, and protein-losing nephropathy.
Perform a risk assessment of patient-specific thrombotic risk factors and comorbidities in complex cases, including those requiring advanced interventions like extracorporeal therapies.
Justify therapeutic choices of antithrombotic and thrombolytic medications by considering guideline-based dosing, monitoring, and potential complications when managing arterial and venous thromboembolism in dogs and cats.
